Skip to main content
. 2020 Aug 10;9(8):2591. doi: 10.3390/jcm9082591

Table 2.

Common prescribed drugs in our cohort of patients that can contribute to drug-induced LQTS/torsade de pointes. Risk categories depend on whether drugs can cause QT prolongation or torsade de pointes: the Long QT-JT index used to derive the LQTS risk score and CredibleMeds are presented.

Drug Names Number of Patients, N (%) Long QT-JT Index Category * CredibleMeds Category ŧ
Furosemide 2629 (21%) Moderate Conditional
Pantoprazole 2402 (19%) Moderate Conditional
Sertraline 1583 (12%) Low Conditional
Trazodone 1479 (11%) High Conditional
Famotidine 1422 (11%) Moderate Conditional
Omeprazole 1395 (11%) Moderate Conditional
Hydrochlorothiazide 1359 (10%) Moderate Conditional
Donepezil 1073 (8%) Moderate Known
Mirtazapine 1004 (8%) Moderate Possible
Quetiapine 853 (6%) High Conditional
Escitalopram 752 (6%) High Known
Citalopram 681 (5%) High Known
Risperidone 500 (4%) High Conditional
Mirabegron 429 (3%) Low Possible
Aripiprazole 400 (3%) Moderate Possible
Venlafaxine 380 (3%) High Possible
Fluoxetine 357 (2%) Moderate Conditional
Olanzapine 270 (2%) Low Conditional
Esomeprazole 216 (1%) Moderate Conditional
Amiodarone 212 (1%) High Known
Ondansetron 177 (1%) High Known
Paroxetine 182 (1%) Moderate Conditional
Loperamide 154 (1%) High Conditional

* Long QT-JT Index values ≤ 15 are associated with High risk of drug-induced LQTS, values 16–100 are associated with a Moderate risk, and values 101-999 are associated with Low risk. Patient-specific risk (Long QT-JT Score) is determined by using the drug-specific Long QT-JT Index combined with other factors such as age, sinus rhythm, use of diuretics, use of Class 1A,1C or III antiarrhythmic drugs, magnesium and potassium levels, and QT interval value [30]. ŧ CredibleMeds categories are described as follows: Known risk of torsade de pointes is drugs that prolong the interval and are clearly associated with a known risk of torsade de pointes. Conditional risk is drugs associated with torsade de pointes but only under certain conditions of their use or creating conditions that facilitate or induce torsade de pointes. Possible risk is drugs that can cause QT prolongation but have no clear evidence for a risk of torsade de pointes [44].